Kathryn A. Maurer
( out of 172 reviews )

Kathryn A. Maurer, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital North

2K, Gynecology and Mammography
Salt Lake City
801-213-4269

Intermountain Medical Center- Women & Newborn

University Health Specialty Gynecology
Murray
801-587-2809

  • Dr. Kathryn Maurer provides patients with the treatment and management of gynecologic cancers. This includes ovarian, endometrial, cervical, and vulvar cancers, employing both traditional and minimally invasive techniques. She specializes in the minimally invasive management of gynecologic malignancies, comprehensive gynecologic cancer screening, and the evaluation and management of hereditary gynecologic cancer syndromes. Through clinical trials, she is committed to the advancement of the treatment of these cancers.

    Dr. Maurer is currently accepting new patients on a referral basis. For more information, please call the women’s health services at 801-213-2995.

    Dr. Maurer earned her Sc.B. in Geology and Biology from Brown University and her Medical Degree from the University of Michigan Medical School. She completed her residency in Obstetrics and Gynecology at the University of Utah School of Medicine, followed by a fellowship in Gynecologic Oncology at the Cleveland Clinic in Ohio. She is board-certified in Obstetrics and Gynecology, with a subspecialty certification in Gynecologic Oncology from the American Board of Obstetrics & Gynecology.

    Her academic role is as a Gynecologic Oncologist and Assistant Professor at the University of Utah School of Medicine and the Huntsman Cancer Institute. Dr. Maurer educates the next generation of medical professionals. Her clinical practice at the Huntsman Cancer Institute is focused on providing exceptional care and improving outcomes for patients with gynecologic cancers. is a gynecologic oncologist and assistant professor at the University of Utah School of Medicine and the Huntsman Cancer Institute.

    Specialties

    Board Certification

    American Board of Obstetrics & Gynecology
    American Board of Obstetrics & Gynecology (Sub: Gynecologic Oncology)

    Patient Rating

    4.9 /5
    ( out of 172 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    February 26, 2025
    HUNTSMAN CANCER CENTER

    She is the best!

    January 09, 2025
    HUNTSMAN CANCER CENTER

    Brilliant doctor'very kind and compassionate. She was honest but not brutal.

    January 03, 2025
    HUNTSMAN CANCER CENTER

    She is great. She makes me feel welcome and I trust her.

    December 31, 2024
    HUNTSMAN CANCER CENTER

    Dr. Maurer is the best. She is very focussed on you as a patient and is very kind. She is very knowledgeable. Huntsman is a great team.

    December 13, 2024
    HUNTSMAN CANCER CENTER

    Just amazing!!!

    November 27, 2024
    HUNTSMAN CANCER CENTER

    Dr Maurer embodies the definition of a professionalism. Throughout the visit, her every action was kind, attentive and knowledgeable. She was fully present in every moment, and answered every question with thoughtful well-considered insight. I feel very comfortable and relaxed to put the next steps of my care into her competent hands.

    November 27, 2024
    HUNTSMAN CANCER CENTER

    Dr. Maurer took the time to explain the process and answer all my questions. She explained in a simple format- I definitely recommend seeing her!

    October 29, 2024
    HUNTSMAN CANCER CENTER

    Dr. Maurer provides excellent medical care!

    October 29, 2024
    HUNTSMAN CANCER CENTER

    Dr. Maurer is amazing! Exceptional skills coupled with compassionate honesty make her a trusted surgeon.

    See More Patient Comments

  • Dr. Kathryn Maurer provides patients with the treatment and management of gynecologic cancers. This includes ovarian, endometrial, cervical, and vulvar cancers, employing both traditional and minimally invasive techniques. She specializes in the minimally invasive management of gynecologic malignancies, comprehensive gynecologic cancer screening, and the evaluation and management of hereditary gynecologic cancer syndromes. Through clinical trials, she is committed to the advancement of the treatment of these cancers.

    Dr. Maurer is currently accepting new patients on a referral basis. For more information, please call the women’s health services at 801-213-2995.

    Dr. Maurer earned her Sc.B. in Geology and Biology from Brown University and her Medical Degree from the University of Michigan Medical School. She completed her residency in Obstetrics and Gynecology at the University of Utah School of Medicine, followed by a fellowship in Gynecologic Oncology at the Cleveland Clinic in Ohio. She is board-certified in Obstetrics and Gynecology, with a subspecialty certification in Gynecologic Oncology from the American Board of Obstetrics & Gynecology.

    Her academic role is as a Gynecologic Oncologist and Assistant Professor at the University of Utah School of Medicine and the Huntsman Cancer Institute. Dr. Maurer educates the next generation of medical professionals. Her clinical practice at the Huntsman Cancer Institute is focused on providing exceptional care and improving outcomes for patients with gynecologic cancers. is a gynecologic oncologist and assistant professor at the University of Utah School of Medicine and the Huntsman Cancer Institute.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Assistant Professor (Clinical)
    Academic Divisions Gynecological Oncology
    Board Certification
    American Board of Obstetrics & Gynecology
    American Board of Obstetrics & Gynecology (Sub: Gynecologic Oncology)

    Education history

    Fellowship Gynecologic Oncology - Cleveland Clinic Fellow
    Residency Obstetrics and Gynecology - University of Utah School of Medicine Resident
    Professional Medical Medicine - University of Michigan Medical School M.D.
    Undergraduate Geology, Biology - Brown University Sc.B.

    Selected Publications

    Journal Article

    1. Barnard ME, Farland LV, Yan B, Wang J, Trabert B, Doherty JA, Meeks HD, Madsen M, Guinto E, Collin LJ, Maurer KA, Page JM, Kiser AC, Varner MW, Allen-Brady K, Pollack AZ, Peterson KR, Peterson CM, Schliep KC (2025). Endometriosis Typology and Ovarian Cancer Risk. JAMA, 332(6), 482-489. (Read full article)
    2. Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson BD (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstet Gynecol, 140(5), 806-811. (Read full article)
    3. Straubhar AM, Parsons MW, Francis S, Gaffney D, Maurer KA (2021). Refusal of surgery and survival outcomes in endometrial cancer. Int J Gynecol Cancer, 31(9), 1236-1241. (Read full article)
    4. Casper AC, Parsons MW, Chipman J, Burt LM Jr, Suneja G, Maurer KA, Gaffney DK (2021). Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up. Gynecol Oncol, 162(2), 454-460. (Read full article)
    5. Parsons MW, Francis S, Maurer KA, Grant J, Gaffney DK (2020). Refusal of Radiation Results in Inferior Survival in Endometrial Cancer. Am J Clin Oncol, 43(6), 399-410. (Read full article)
    6. Harris KL, Maurer KA, Jarboe E, Werner TL, Gaffney D (2019). LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT? Gynecol Oncol, 156(1), 243-250. (Read full article)
    7. McComas KN, Torgeson AM, Ager BJ, Hellekson C, Burt LM, Maurer KA, Werner TL, Gaffney DK (2019). The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system. Gynecol Oncol, 156(1), 85-92. (Read full article)
    8. Rodriguez AC, Blanchard Z, Maurer KA, Gertz J (2019). Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions. Horm Cancer, 10(2-3), 51-63. (Read full article)
    9. Gaffney DK, Hashibe M, Kepka D, Maurer KA, Werner TL (2018). Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol, 151(3), 547-554. (Read full article)
    10. Maurer K, Michener C, Mahdi H, Rose PG (2016). Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions. J Gynecol Oncol, 28(4), e38. (Read full article)

    Case Report

    1. Wei M, Maurer KA, Henry NL (2019). Ovarian remnant syndrome in an aromatase inhibitor-treated patient with BRCA2 mutation following bilateral oophorectomy. Breast J, 25(6), 1254-1256. (Read full article)